A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese

计划入组 100 人 · 首次发布于 2026 年 2 月 17 日

Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?

计划入组 30 人 · 首次发布于 2010 年 1 月 13 日

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

计划入组 24 人 · 首次发布于 2025 年 1 月 14 日

ZP-I-98

Gastric inhibitory polypeptide

Glucose(Bss Ophthalmic Solution, Citrasate, Clinimix 2.75/5, Clinimix E 2.75/5, Dextroject, Dianeal, H.E.L.P.bicel, Hemosate Ultra, Lactate 1-2-3, Leukotrap, Naturalyte, Nauzene, Normosol-R, Nxstage Pureflow, Olimel, Periolimel, Physioneal 40, Sag-M, Sclerodex, Selectbag One)

Rx

PolyPeptide Group AG

Switzerland

Arvinas Estrogen Receptor, Inc.

United States

POLYPEPTIDE LABORATORIES FRANCE

France

Stimulating fat cells with GIP receptor has potential to treat obesity

GIP Reduces Free Fatty Acids via 11β-HSD1 Inhibition in Adipose Tissue

GLP-1 Receptor Agonists Spearhead Obesity Treatment Advancements